Will Ashworth

Will Ashworth

InvestorPlace Contributor

Expertise: Public and private companies, Portfolio construction

About Will:
Will Ashworth has written about investments full-time since 2008. He loves investing and is passionate about helping others put their money to work. He particularly enjoys creating model portfolios that stand the test of time.

Publications where he’s appeared include InvestorPlace, The Motley Fool Canada, Investopedia, Kiplinger, and several others in both the U.S. and Canada. He lives in Halifax, Nova Scotia.

You can follow Will on LinkedIn. 

Recent Articles

Does Facebook’s Libra Currency Change the Outlook of Visa Stock?  

By Will Ashworth, InvestorPlace Contributor

The announcement of the Libra cryptocurrency from FB has investors talking. Should the owners of Visa stock be concerned? 

Can Roku’s International Expansion Drive Roku Stock Higher?

By Will Ashworth, InvestorPlace Contributor

In recent trades, Roku stock has experienced a lull in sentiment. However, the opportunities in the international markets provide reason for optimism.

Should Debt Hold You Back From Buying CVS Stock? We’re Of Several Opinions

By Will Ashworth, InvestorPlace Contributor

CVS Health added a lot of debt when it acquired Aetna for $69 billion. Should the company's balance sheet hold you back from buying CVS stock? 

7 Retail Stocks to Buy That Are Down in 2019

By Will Ashworth, InvestorPlace Contributor

Retailers have some of the worst-performing stocks in 2019, but these are seven retail stocks to buy to buck the trend.  

Is Intel Stock About to Get Burned by Microsoft?

By Will Ashworth, InvestorPlace Contributor

Rumors indicate that Microsoft is seeking alternatives for chip providers for their Surface tablets. That hurts a revenue channel for Intel, but it's not necessarily a reason to panic on INTC stock.

3 Reasons Cronos Group Stock Deserves A Buy Rating

By Will Ashworth, InvestorPlace Contributor

Cronos currently has a market cap of $5.4 billion. In the first quarter, it closed the Altria investment. At the end of March, it had $1.8 billion in cash on the balance sheet. CRON stock is trading at less than 3x cash.

Facebook Stock Is Great, but FB Is a Terrible Company

By Will Ashworth, InvestorPlace Contributor

Facebook is having a great year in the markets with FB stock up 47% in 2019. If you’re concerned about ESG, I’d stay away from FB. 

Can Vaping Growth Help Investors Extract More Value From Aphria Stock?

By Will Ashworth, InvestorPlace Contributor

Aphria's interim CEO recognizes that vape products are growing while dried flower is slowing. That trend is one of the multiple catalysts likely to fuel APHA stock in the next year.

7 Stocks to Buy for the Same Price as Beyond Meat

By Will Ashworth, InvestorPlace Contributor

You could pick up one share of each of these stocks to buy for roughly the same price as one share of Beyond Meat stock.

If You Have the Stomach, $15 Is the Buy Zone for IQ Stock

By Will Ashworth, InvestorPlace Contributor

Although I like the fact that the video-streaming service has four revenue streams: membership services, advertising, content distribution, and live broadcasting/online games, the fact that it lost $270 million in the first quarter compared to $59 million a year earlier suggests the risk of owning IQ stock is high.

Load More